Research / News

Research News

Filtered:

Major organ surgery (Remove filters)

BioPorto receives Frost & Sullivan Award

Frost & Sullivan awards AKI Product Leadership Award to BioPorto

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

Product launch - Human NGAL monomer-specific ELISA

BioPorto launches the first human NGAL monomer specific assay. 

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity, AKI treatment, Other
Date

Acute Kidney Biomarkers in focus in renown clinical issue

American Association for Clinical Chemistry (AACC) push for AKI biomarkers including NGAL in new cover story

Read more
Category
Diagnostics, Research
Clinical Relevance
Intensive care (ICU), Major organ surgery, Transplantation
Date

A new rapid NGAL assay for clinical chemistry platforms

A new assay simply known as The NGAL Test makes it possible to get an earlydiagnosis of acute kidney injury.

Read more
Category
Research
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

New Dog NGAL ELISA

BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in urine, plasma and serum from dogs.

Read more
Category
Research
Clinical Relevance
Major organ surgery, Transplantation, Nephrotoxicity
Date